Table 2 CMR results
| Â | All n = 80 | Male n = 45 | Female n = 35 |
|---|---|---|---|
LV ejection fraction, % (range) | 58 (38–73) | 57 (45–73) | 61 (38–71) |
LV systolic dysfunction, n (%) | 20 (25%) | 16 (36%) | 4 (11%) |
LV enddiastolic volume, ml/m2 (range) | 72 (38–117) | 77 (41–117) | 67 (38–104) |
LV endsystolic volume, ml/m2 (range) | 31 (11–63) | 35 (14–63) | 28 (11–56) |
LV dilatation, n (%) | 7 (9%) | 6 (13%) | 1 (3%) |
LV mass, g/m2 (range) | 47(30–79) | 50 (36–79) | 41(30–67) |
LV wall hypertrophy, n (%) | 6 (8%) | 4 (9%) | 2 (6%) |
RV ejection fraction, % (range) | 64 (38–77) | 60 (38–77) | 67 (50–76) |
RV systolic dysfunction, n (%) | 4 (5%) | 4 (9%) | 0 |
RV enddiastolic volume, ml/m2 (range) | 66 (40–117) | 71 (40–117) | 61 (40–102) |
RV endsystolic volume, ml/m2 (range) | 23 (10–66) | 28 (10–66) | 20 (10–46) |
RV dilatation, n (%) | 1 (1%) | 1 (2%) | 0 |
RV outflow tract, mm (range) | 26 (21–37) | 27 (22–37) | 25 (21–29) |
Myocardial fibrosis, n (%) | 10 (13%) | 7 (16%) | 3 (9%) |